Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. (Source: Bloomberg)
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/f330a7e3f351dcaf52525414666797f79b545541" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Lilly to Buy Merida for $2.88B in Autoimmune Push"></iframe>
